More
    Guided Solutions - Connecting Talent With Innovation/div>

    Cognixion launches trial of BCI device paired with AI application for people with ALS

    Cognixion announced today that it launched a clinical trial evaluating its integrated, wearable augmented reality and BCI device. The clinical trial evaluates the Axon-R device paired...

    Second Heart Assist’s Whisper device caused less hemolysis compared to Abiomed Impella CP

    Second Heart Assist announced data from a study highlighting the performance of its Whisper device against a competitive heart pump. The study showed that...

    Lungpacer wins FDA IDE for AeroNova system

    Lungpacer Medical received FDA investigational device exemption (IDE) to begin a trial for its AeroNova system. The STARI (stimulation to activate respiration) trial evaluates the...

    Neuspera has positive data for percutaneous sacral neuromod system

    Neuspera Medical announced six-month pivotal clinical trial data highlighting the efficacy of its battery-free percutaneous sacral neuromodulation (pSNM) system. Findings showed comparable efficacy with the...

    CereVasc treats first patient with eShunt system in its STRIDE clinical trial

    CereVasc today announced the first patient randomised to and treated with the eShunt system in its STRIDE clinical trial. STRIDE, a head-to-head comparison, pits the...

    Onward reports positive spinal cord stim results for ARC-EX

    Onward Medical shared positive study results from an evaluation of its ARC-EX spinal cord stimulation therapy system. Results from the investigator-sponsored Pathfinder 2 study,...

    WhiteSwell has positive data for its fluid removal system eLym

    WhiteSwell announced positive data from 21 patients treated in a trial evaluating its eLym system for fluid removal. The company also announced FDA breakthrough...

    MicroTransponder Vivistim nerve stim tech delivers positive stroke outcomes

    MicroTransponder announced positive real-world outcomes for its Vivistim vagus nerve stimulation (VNS) system. Data highlighted Vivistim’s impact when paired with occupational or physical therapy to...

    Wellumio’s portable MRI device trial enrols first subject in Australia

    Wellumio has enrolled the first subject in the Portable MRI study of its magnetic resonance imaging (MRI) device, ‘Axana’ 0.1T, for stroke identification in...

    Latest articles